Exchange: NASDAQ·Updated 07:30 PM EDT
CRBP logo

CRBP Corbus Pharmaceuticals Holdings Inc

$11.33
$0.01
(0.09%)
Today
Closed $11.30
$0.03
(0.27%)
After Hours
Reported EarningsAug 6
Mkt Cap$218.75M
Vol392,194.00

About CRBP

Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.
60

Bullish Sentiment

How do you feel about CRBP?

Advertisement|Remove ads.